ENT & Bronchoscopy Devices Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedSuite - Includes: ENT Endoscopes, ENT Powered Instruments, and 9 more
In 2022, the global market for ENT endoscopic and bronchoscopic devices was valued at $6.8 billion. It is expected to grow at a compound annual growth rate (CAGR) of 5.4% during the forecast period, reaching $9.9 billion.
The comprehensive report collection on the worldwide market for ENT endoscopic and bronchoscopic devices includes a wide range of products, such as ENT endoscopes, ENT powered instruments, ENT hand instruments, ENT surgical energy devices, balloon dilation devices, drug-eluting stents, bronchoscopes, bronchoscopic hand instruments, tracheobronchial stents, bronchoscopic biopsy devices, and foreign body removal devices.
MARKET DATA INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
GLOBAL ENT ENDOSCOPIC DEVICE MARKET INSIGHTS
The ENT endoscope market is projected to continue to hold the largest market share in terms of value during the forecast period, mainly due to the increasing demand for single-use endoscopes. Among all the segments in the ENT endoscopic device market, the ENT endoscope market has the highest growth rate, and it is expected to maintain its position as the fastest-growing market by the end of the forecast period.
GLOBAL BRONCHOSCOPIC DEVICE MARKET INSIGHTS
The bronchoscope segment accounted for the largest share of the overall bronchoscopic device market in 2022 and is projected to maintain its dominant position throughout the forecast period. This segment's growth is primarily driven by the increasing sales of single-use and ultrasound bronchoscopes.
GLOBAL ENT DEVICE MARKET SHARE INSIGHTS
The Global ENT device market was lead by Olympus and Karl Storz.
In 2022, Olympus emerged as the leading competitor in the ENT endoscopic and bronchoscopic device market. The company had a significant presence in both the ENT and bronchoscopy device markets. In the ENT endoscopic device market, Olympus held notable market shares in several segments, including ENT endoscopes, powered instruments, hand instruments, and surgical energy devices.
MARKET SEGMENTATION SUMMARY
Global Endoscopic Device Markets:
ENT Endoscope Market – MedCore – Includes:
Subsegments of single-use ENT endoscopes, reusable laryngoscopes, reusable rhinoscopes/sinuscopes, and reusable otoscopes.
ENT Powered Instrument Market – MedCore – Includes:
Total subsegments of capital equipment and disposable markets.
ENT Hand Instrument Market – MedCore – Includes:
Sinus, laryngeal and otological hand instruments.
ENT Surgical Energy Device Market – MedCore – Includes:
Capital equipment and radiofrequency (RF) and ultrasonic probes.
Balloon Dilation Device Market – MedCore – Includes:
Balloon sets, and it does not include the market’s extended set.
Drug-Eluting Stent Market – MedCore – Includes:
Drug-eluting stents only and does not include the market’s extended set.
Global Bronchoscopic Device Markets:
Bronchoscope Market – MedCore – Includes:
Subsegments of rigid, flexible, ultrasound and single-use bronchoscopes.
Bronchoscopic Hand Instrument Market – MedCore – Includes:
Focuses on bronchoscopic hand instruments only and does not include the market’s extended set.
Tracheobronchial Stent Market – MedCore – Includes:
Metal and silicone tracheobronchial stents.
Bronchoscopic Biopsy Device Market – MedCore – Includes:
Segments of bronchial forceps and transbronchial needle aspiration (TBNA) needle devices.
Foreign Body Removal Market – MedCore – Includes:
Disposable and reusable foreign body removal devices.
RESEARCH SCOPE SUMMARY
Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point."
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook